Proficio Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-365
| Closed | -$3K | – | 1377 |
|
|
2019
Q2 | $3K | Sell |
365
-421
| -54% | -$3.46K | ﹤0.01% | 1438 |
|
|
2019
Q1 | $12K | Sell |
786
-76
| -9% | -$1.16K | ﹤0.01% | 834 |
|
|
2018
Q4 | $13K | Sell |
862
-49
| -5% | -$739 | 0.01% | 671 |
|
|
2018
Q3 | $20K | Buy |
911
+8
| +0.9% | +$176 | 0.01% | 598 |
|
|
2018
Q2 | $22K | Buy |
903
+114
| +14% | +$2.78K | 0.01% | 579 |
|
|
2018
Q1 | $13K | Sell |
789
-153
| -16% | -$2.52K | ﹤0.01% | 737 |
|
|
2017
Q4 | $18K | Buy |
942
+862
| +1,078% | +$16.5K | 0.01% | 623 |
|
|
2017
Q3 | $1K | Sell |
80
-69
| -46% | -$863 | ﹤0.01% | 1215 |
|
|
2017
Q2 | $5K | Buy |
149
+53
| +55% | +$1.78K | ﹤0.01% | 971 |
|
|
2017
Q1 | $3K | Sell |
96
-237
| -71% | -$7.41K | ﹤0.01% | 1091 |
|
|
2016
Q4 | $12K | Sell |
333
-295
| -47% | -$10.6K | 0.01% | 569 |
|
|
2016
Q3 | $29K | Sell |
628
-93
| -13% | -$4.3K | 0.02% | 363 |
|
|
2016
Q2 | $40K | Buy |
721
+500
| +226% | +$27.7K | 0.03% | 303 |
|
|
2016
Q1 | $12K | Buy |
221
+30
| +16% | +$1.63K | 0.01% | 391 |
|
|
2015
Q4 | $13K | Buy |
+191
| New | +$13K | 0.01% | 244 |
|